greeksoup/ stock research
Stock research / United States / GMED / FY2010

Globus Medical (GMED) FY2010 results: revenue $288 million

Globus Medical Inc. (GMED) reported revenue of $288 million for fiscal 2010, the year ended 31 December 2010. Net income was $54 million, and diluted earnings per share $0.60. The figures are the company's own, from the 10-K it filed with the SEC on 5 March 2013.

Revenue
$288 million
FY2010FY2010
Operating margin
30.4%
FY2010FY2010
Net income
$54 million
FY2010FY2010
Diluted EPS
$0.60
FY2010FY2010

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2010Last 8 years
Revenue288
Cost of revenue53.8
Gross profit234
Gross margin81.3%
Research and development21.3
Selling, general and administrative123
Operating income87.7
Operating margin30.4%
Pre-tax income87.7
Income tax33.3
Effective tax rate37.9%
Net income54.5
Net margin18.9%
Diluted EPS$0.60
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2010Last 8 years
Operating cash flow71.3
Capital expenditure12.3
Free cash flow59.0
Free cash flow margin20.5%
Cash from investing-12.0
Cash from financing1.8
Depreciation and amortisation15.2
Share-based compensation4.0
Buybacks0.0
Diluted shares, weighted91m

Balance sheet

$ millionFY2010Last 8 years
Shareholders' equity228
Cash and equivalents112

10-K for the year ended 31 December 2010, filed 5 March 2013: the filing.